Justin Cooper

CLEVELAND — Using laser and light devices to treat autoimmune or connective tissue disease sequelae, such as scarring, requires careful consideration, according to a speaker at Cleveland Clinic’s Medical Dermatology Therapy Update IV.“A lot of times, patients with sequelae from their autoimmune or connective tissue disease are turned away,” Shilpi Khetarpal, MD, a cosmetic

Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye diseases, but important nuances remain to be investigated, according to a review published in BMC Ophthalmology.“Although GLP-1 RAs have revolutionized metabolic disease management, their potential therapeutic role in ocular diseases — particularly those

Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the research pipeline, driven by both dermatologic and rheumatologic advancements, according to a speaker.

The currently available body of evidence is not strong enough to support vitamin supplementation as a treatment for dry eye disease, with particular gaps around vitamins C and B12, according to a review.

CLEVELAND — Dermatologists are best positioned to use a combination of interventions to treat hidradenitis suppurativa, including medications and

CLEVELAND — After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see rapid progress, according to a speaker at the Medical Dermatology Therapy Update IV. FDA approvals of the biologic dupilumab (Dupixent, Sanofi and Regeneron) and twice-daily oral therapy remibrutinib (Rhapsido, Novartis) for chronic spontaneous urticaria in 2025

The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone and lenalidomide, according to a review in Graefe’s Archive for Clinical and Experimental Ophthalmology. “Medication-associated TED is an important diagnostic consideration in orbital inflammatory disease,” Terence Ang, PhD, of University of Adelaide, Australia, and

To manage dry eye symptoms in Sjögren's disease, use preservative-free eye drops and treat meibomian gland dysfunction, according to a paper published in Journal of Clinical Medicine

DENVER — Compared with original Lumify eye drops, a new formulation with sodium hyaluronate led to comparable reductions in eye redness, according to phase 3 data presented here.